Sign inJoin waitlistJoin the waitlist

Katharine Offer

Associate Fellowship Director, Pediatric Hematologist-Oncologist · Hackensack Meridian Health

Credentials: · ·

History

Pediatric Hematologist-Oncologist · Hackensack Meridian Health
Present
Hackensack Meridian Health
Present

Memorial Sloan Kettering Cancer Center
2014–2015
Pediatrics
Morgan Stanley Children's Hospital of New York Presbyterian
2011–2014
Hackensack University Medical Center
2007–2011

Research

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Cell · 2020 · 1,025 citations
Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis
Nature Cell Biology · 2019 · 355 citations
Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling…
Biology of Blood and Marrow Transplantation · 2015 · First of 11 authors · 20 citations

Prakash Satwani
5 papers
AC
Alexander Chou
4 papers
Kayleen Bailey
4 papers · 2 as a fellow
Adit Tal
3 papers
AO
Andrea Orsey
3 papers
Anshul Vagrecha
3 papers
Gabriel Robbins
3 papers
Jennifer Levine
3 papers
Jeremy Rosenblum
3 papers
JP
Joanna Pierro
3 papers
Scott Moerdler
3 papers
SR
Stephen Roberts
3 papers

Clinical trials

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Principal investigator · Recruiting · Phase 2
Hackensack Meridian Health
2024–2027
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Milton S. Hershey Medical Center
2024–2035
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027